Vonoprazan
Back to searchMolecule Structure
Scientific Name
Vonoprazan
Description of the Drug
Vonoprazan is a potassium-competitive acid blocker used in the treatment of acid-related disorders and as an adjunct to Helicobacter pylori eradication.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11739
http://www.drugbank.ca/drugs/DB11739
Brand Name(s)
Takecab, Vocinti
Company Owner(s)
Phathom Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Potassium-transporting ATPase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2095173 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL194487 |
| Human Metabolome Database | HMDB0259872 |
| DrugBank | DB11739 |
| PubChem: Thomson Pharma | 24260313 |
| PubChem | 15981397 |
| Nikkaji | J2.908.904C |
| PDBe | HKT |
| BindingDB | 394392 |
| EPA CompTox Dashboard | DTXSID20236869 |
| DrugCentral | 4993 |
| ChemicalBook | CB22716734 |
| ChEBI | 136048 |
| ZINC | ZINC000034842823 |
